INSIDERFilingvia Quantisnow
Codiak BioSciences Inc. logo

Codiak BioSciences (CDAK) executive Bain received 80,000 Restricted Stock Units

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Linda Bain (executive at Codiak BioSciences Inc., CDAK) reported that they received 80,000 Restricted Stock Units on Sep 16, 2022.

Reporting person
Bain Linda

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Sep 16, 2022Grant or award (A)Restricted Stock UnitsOn 80,000 Common Stock1, 2+80,000--80,000 direct

Holdings before and after

  • Restricted Stock Units: 0 to 80,000 direct

Footnotes from the filing

  1. 1. Each restricted stock unit represents a contingent right to receive one share of common stock.
  2. 2. On September 16, 2022, the reporting person was granted 80,000 restricted stock units, vesting on June 30, 2023.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Bain report in this CDAK Form 4?

Linda Bain (executive at Codiak BioSciences Inc., CDAK) reported that they received 80,000 Restricted Stock Units on Sep 16, 2022.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CDAK

Earlier insider filings at CDAK

Quantisnow market dataNASDAQ
Codiak BioSciences Inc. logo
CDAK
Codiak BioSciences Inc.
Market cap
30-day
Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Listed since
2020
Get push alerts for CDAK

Follow CDAK and get a push notification the moment its next story breaks.

Full CDAK profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDAK (Codiak BioSciences Inc.) and more on Quantisnow.